The other top-paid board chairs worked in the financial services or industrial products industry.
The highest paid nonexecutive board members in pharma in 2018:
1. P. Roy Vagelos (Regeneron Pharma) — $6.3 million
2. Omid Farokhzad (Selecta Biosciences) — $1.4 million
3. Steven Lund (Nu Skin Enterprises) — $1.3 million
4. Kevin Starr (Sage Therapeutics) — $1.1 million
5. Iain Dukes (Iovance Biotherapeutics) — $1 million
6. Daniel Lynch (Bluebird Bio) — $1 million
7. Daniel Lynch (Surface Oncology) — $1 million
Daniel Lynch is a board chair at both Bluebird Bio and Surface Oncology.
More articles on pharmacy:
Average chief pharmacy officer salary by state
2020 election brewing ‘perfect storm’ for drug-pricing reform, analyst says
Colombia fines Pfizer $25K for drug price inflation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.